|
Daily Medical Update
Euthyroid sick syndrome
Tuesday, September 29, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Clinica chimica acta; international journal of clinical chemistry (2026) - Meta-Analysis
Key Findings
- Severe-to-critical COVID-19 cases had consistently reduced total and free T3 levels compared with less severe cases.
- Thyroid dysfunction was associated with a 4.8-fold increase in the odds of severe-to-critical disease, while TSH alone did not predict severity.
- Higher total and free T3 concentrations were consistently associated with a milder clinical course and reduced severe-disease risk.
📋 Practice Implication: Low TT3 or FT3 may help identify patients with COVID-19 at higher risk of severe disease, but the evidence does not yet support routine thyroid monitoring as a treatment-guiding intervention.
|
Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) (2026) - Review
Key Findings
- Low T3 with elevated reverse T3 was identified as the principal biochemical pattern, and NTIS incidence increased with critical-illness severity.
- NTIS was associated with increased mortality among critically ill patients and worsening outcomes across infectious, cardiovascular, renal, pulmonary, metabolic, and autoimmune illnesses.
- Serial T3 and reverse-T3 testing was described as useful for estimating illness phase and identifying patients at increased mortality risk during ICU treatment.
📋 Practice Implication: Interpret the low-T3 pattern as a marker of systemic illness and disease phase, reserving conclusions about intrinsic thyroid failure for the broader clinical and biochemical context.
|
Clinical medicine insights. Endocrinology and diabetes (2026) - Case Report
Key Findings
- Rapid 22-kg weight loss over 4 months after semaglutide initiation was associated with reduced FT3, low-normal FT4, and inappropriately low-normal TSH.
- After primary thyroid and pituitary disease were excluded, the reduced thyroid hormone pattern was attributed to a catabolic state rather than intrinsic thyroid pathology.
📋 Practice Implication: When substantial GLP-1-associated weight loss accompanies low T3 and nonspecific symptoms, assess nutritional and systemic context before diagnosing hypothyroidism or starting replacement therapy.
|
Medicina (Kaunas, Lithuania) (2025) - Observational Study
Key Findings
- ESS was present in 49.0% of 386 ICU patients receiving NIV and in 66.7% of deceased patients versus 46.1% of survivors.
- NIV failure occurred in 44.4% of patients with ESS versus 26.4% without ESS (p < 0.001).
- Prolonged low FT3 before and during ICU admission was more common among deceased patients than survivors (58.3% vs. 26.1%).
📋 Practice Implication: In NIV-treated ICU patients, ESS—especially persistent low FT3—can be used as an early risk signal to intensify respiratory monitoring and reassess escalation planning.
|
Children (Basel, Switzerland) (2026) - Observational Study
Key Findings
- ESS occurred in 61.5% of children with DKA; 64.3% had combined low FT4/FT3 and 35.7% had isolated low FT3.
- After 2 weeks, all ESS patients had normalization of at least one thyroid hormone; complete normalization occurred in 36.6% and FT3 normalization in 38.4%.
- FT4 normalization was lower after severe DKA than after mild or moderate DKA (50.0% vs. 84.8%, p = 0.002).
📋 Practice Implication: During pediatric DKA, defer labeling primary thyroid disease and repeat thyroid testing after metabolic recovery, because ESS is common but full biochemical normalization may lag in severe acidosis.
|
|
💡
Summary
Across the selected evidence, euthyroid sick syndrome (ESS), or non-thyroidal illness syndrome, is primarily a low-T3 pattern accompanying acute or systemic stress, with prognostic significance varying by context. Meta-analytic and cohort data associate low thyroid hormone patterns with more severe COVID-19, higher NIV failure and mortality in ICU patients, while pediatric DKA data show frequent but incomplete biochemical recovery after stabilization. A semaglutide-associated rapid-weight-loss case further underscores the need to distinguish transient adaptive changes from primary thyroid disease and interpret testing in clinical context.
|
|